When it comes to pharma CEOs as social influencers, Pfizer’s Albert Bourla is a perfect 10 compared to his peers.
Novartis CEO Vas Narasimhan is a close second, though, with a 9.2 social impact rating — and his status is on the rise, according to Creation Healthcare’s new analysis of pharma CEO social influence.
The CREATION Healthcare analysis compared pharma leaders against each other based on the number of followers, frequency of posts, number of likes received, and the number of comments, both by the CEO and from readers, across social media channels. LinkedIn was by far the most popular platform for pharma CEOs.
Daniel Ghinn, chief executive of Creation Healthcare, said its research suggested that concerns about workload, conditions and patient safety appeared to be significant drivers of the decision to strike, as well as pay. This suggested any pay settlement would offer respite only “in the short to medium term”, he said.
Also on Nov. 16, the FDA announced the approval of AstraZeneca’s Truqap (capivasertib with fulvestrant) for the treatment of hormone receptor-positive/HER2-negative metastatic breast cancer. After its approval, Paolo Tarantino, MD, a research fellow at the Dana-Farber Cancer Institute, sparked conversation related to a subanalysis of the CAPItello-291 trial, which was presented at the San Antonio Breast Cancer Symposium. Overall, HCPs expressed support for its approval, particularly in its capacity as another treatment option for patients with breast cancer.
The findings form part of a wider study by leading digital insights consultancy Creation Healthcare, and are based on the analysis of 2,313 English-language posts on X (formerly Twitter) by 1,633 HCPs throughout November, focusing on the approval and launch of new products.
Click here to read the full article
Creation.co, a specialist digital insights consultancy, is able to track the conversations happening on the platform, and found that less than 2% of HCPs discussing the potential paywall expressed support of the idea.
Further, posts by HCPs showed that in the immediate aftermath of the comments, the number of registrations to a rival social media platform, BlueSky, had ‘dramatically increased’. According to Creation, the general sentiment expressed by HCPs was one of resentment towards potentially losing their network of medical professionals, built up over the years of using the platform.
When asked directly about the likely impact on HCPs with the imposition of a paywall, Jamie Doggett, associate director of insight at Creation, stated: “It’s clear from Creation’s studies of the digital behaviours of HCPs that X provides a unique tool for peer collaboration, and it’s still the biggest network of millions of HCPs tracked by Creation Pinpoint. We have, however, tracked HCPs saying that they refuse to pay for X. It does seem clear that charging for X will drive away some, if not all, HCPs from the platform.”
Read the full article here
The findings form part of a wider study by leading digital insights consultancy, Creation Healthcare, and are based on an analysis of 2,379 English-language posts on X, the platform formerly called Twitter, by 1,555 HCPs throughout September 2023 surrounding the approval and launch of new products.
The analysts found that fewer HCPs discussed treatment approvals compared with the previous month, with 14% fewer product launch mentions compared with those in August.
Read the full article here
Creation Healthcare, a leading health care insights consultancy, used CREATION Pinpoint to analyze 2,896 English-language posts generated by 1,889 HCPs on X — formerly Twitter — from Aug. 1 to Aug. 30 to identify key aspects of discussions about FDA approvals and product launches.
Click here to read the full article
Last month, Meta, the tech giant behind Facebook, Instagram, and WhatsApp, announced the launch of Threads: a direct challenger to its now rebranded rival, X (Twitter).
Within five days, the platform had clocked up 100 million sign-ups. It wasn’t long before Elon Musk took to X to make his displeasure known. But the arrival of the new kid on the block holds implications far beyond Silicon Valley. With 370 million users worldwide, for many X has become an indispensable tool to share information both in their personal and professional lives.
Healthcare is no exception. From Turin to Tokyo, every day hundreds of thousands of healthcare professionals take to X to share professional insights and to seek solutions to clinical challenges. The implications of Threads and the impact it poses for this information sharing is significant.
Analysis of the online conversation among health care professionals on social media in July revealed significant online discussion and support for the first-ever nonprescription daily oral contraceptive, norgestrel 0.075 mg.
In addition to norgestrel 0.075 mg (Opill, Perrigo), the analysis revealed two other spikes in online conversation among health care professionals (HCPs) surrounding donislecel (Lantidra, CellTrans), the first cellular therapy to treat patients with type 1 diabetes, and lecanemab-irmb (Leqembi, Eisai), the new treatment for Alzheimer’s disease.
The findings form part of a wider study by Creation Healthcare, a leading digital insights consultancy, and are based on the analysis of 2,882 English-language posts on X (Twitter) by 2,037 HCPs throughout July surrounding the approval and launch of new products.
Lung cancer was a significant focus of social media conversation among healthcare professionals (HCPs) at this year’s annual American Society of Clinical Oncology (ASCO) conference, analysis has shown.
Research by digital insights consultancy, Creation Healthcare, found mentions of lung cancer featured in over 9,000 social media posts generated by 2,632 HCPs from across the globe during the period 1 May to 8 June 2023. Of the 9,000 posts, 43 per cent fell between the four days of the conference (2 to 6 June 2023) amounting to 15 per cent of the total ASCO 23 online conversation.
Click here to read the full article
But with record staff vacancies, huge waiting lists and months of industrial action, the celebrations could be overshadowed by the current crisis facing the health service.
Research carried out for ITV Meridian by Creation Healthcare shows that shortages of doctors and nurses are the biggest concern amongst those working in the health service.
Click here to read the full article
Early analysis suggests that a greater proportion of healthcare professionals (HCPs) online have expressed negative sentiment toward the new Meta Threads platform compared to those who are positive.
The findings, produced by digital insights consultancy, Creation Healthcare, undermine speculation surrounding Threads’ capacity to usurp its more established rival, X (Twitter) and indicate that the transfer of HCP networks from Twitter to Threads may be limited.
Click here to read the full article
Social media should play a bigger part in public health crisis planning, according to a recent analysis from digital health consulting firm Creation Healthcare.
The analysis explored the crucial role that Twitter and other social media platforms played when the app for Abbott’s FreeStyle Libre system crashed earlier this month for iOS users the U.K.
Click here to read the full article
Anni Neumann, a pharmaceutical digital insights consultant with over ten years’ industry experience, including almost seven years at leading digital insights consultancy Creation Healthcare, has been elected to the board of the British Healthcare Business Intelligence Association (BHBIA).
As an organisation, the BHBIA works to support those working in healthcare market research and data analytics by driving best practice in insight generation.
Click here to read more
Creation Healthcare — a leading health care insights consultancy — used CREATION Pinpoint to analyze 2,817 Twitter posts generated by 1,949 HCPs to identify key aspects of the discussions about FDA approvals of pharmaceutical products from June 1 through June 30.
They studied HCPs’ reactions and thoughts surrounding several product approvals to discover which new product launches they are discussing, as well as #WhatHCPsThink.
Click here to read the full article
Consultants taking strike action enjoy less support among their health-worker colleagues than nurses did, analysis suggests.
Thousands of consultants walking out have reduced NHS services to Christmas Day levels on Thursday and Friday this week, providing emergency cover only.
Click here to read the full article
Creation Healthcare analyzed 3,402 Twitter posts generated by 2,369 health care professionals (HCPs) discussing new pharmaceutical product launches and drug approvals from May 1 to May 31, 2023, with CREATION Pinpoint®. They studied HCPs’ reactions and thoughts surrounding several product approvals to discover which new product launches they are discussing, as well as #WhatHCPsThink. The data included mentions of drug approvals by the FDA, European Medicines Agency, National Institute for Health and Care Excellence and the Committee for Medicinal Products for Human Use, as well as mentions of drug approvals by HCPs in their Twitter conversations.
Click here to to read the full article
Anni Neumann, a pharmaceutical digital insights consultant with over ten years’ industry experience, including almost seven years at leading digital insights consultancy Creation Healthcare, has been elected to the board of the British Healthcare Business Intelligence Association (BHBIA).
Social media is unique in its capacity to gather insight into the thoughts and opinions of large numbers of healthcare professionals (HCPs) quickly.
Indeed, new research has offered insight into the applications of social media among HCPs treating, and patients suffering from, rare diseases such as lupus, myasthenia gravis, sickle cell, and multiple sclerosis. It shows how social media offers patients a community where they can share and discuss their symptoms with others living with rare diseases, but also how it can offer those treating patients a place to share their experiences, seek advice, or discuss the efficacy of new and novel treatments.
Click here to read the full article
Leading digital pharma and health insights consultancy, Creation Healthcare, has been awarded the prestigious British Healthcare Business Intelligence Association’s (BHBIA) Analyst Team of the Year award. The Creation Healthcare team were given the award at the Best of Business Intelligence Awards (BOBI) last week (12 June) in London.
The award was given to the team of analysts who “best showcased their skills in turning complex datasets into an interactive, engaging report that tells a story within the data”. Teams were given just 24 hours to develop their report after being given the brief.
Analysts at the digital insights consultancy Creation Healthcare examined online conversations of more than 4,500 health care professionals (HCPs) from more than 100 countries from January 2022 to March 2023.
The analysis considered then-current events, such as World Obesity Day, the FDA’s Jan. 3 approval of once-weekly semaglutide (Wegovy, Novo Nordisk) for adolescents with obesity and the AAP’s updated guidance from Jan. 9, which recommended weight loss medication and to evaluate teens for bariatric surgery
The analysis from Creation Healthcare offers insight into key events and factors driving the online conversation over medical cannabis prescription among healthcare professionals over the period, such as the impact of EU-UK trade restrictions disrupting the supply of medical cannabis from the Netherlands in early 2021.
The women chosen by Creation Healthcare are established opinion leaders and women with emerging influence. They hold a range of professional roles, ranging from directors of eminent institutions to younger oncologists. Several metrics were used to evaluate DOL status, including volume of activity, the reach of and engagement with content, the strength of their healthcare professional (HCP) peer network and the level of trust and two-way collaboration with peers online.
One intention is to “[recognize and celebrate] the women and girls who are championing the advancement of transformative technology and digital education.”
In line with this goal, CREATION.co celebrates five female digital opinion leaders in oncology, all of whom use digital means to educate their medical peers, and achieve social change or optimal medical practice.
The analysis found more than 3,900 UK health professionals using their social media accounts to discuss potential strike action since the start of 2021. Posts on this topic have “soared” in recent months amid union ballots.
Online support for strikes among health professionals grew from 59% in September 2021 to 85% in September 2022, and many of those pressing for strikes were doing so because of fears about current “dangers to patient safety” within the health service.
These are the findings of new analysis carried out by specialist digital insights consultancy firm, Creation Healthcare, which explored conversations among health professionals on social media.
Click here to Read more
Medical studies from as early as the 1960s have documented psilocybin’s potentially negative effects — typically “bad trips” (ie, experiences of fear or dysphoria).
However, an increasing amount of research has explored its use to treat drug dependence, anxiety or mood disorders. In some cases, psychedelic drugs such as psilocybin have been deemed less harmful than alcohol or tobacco.
An analysis of social media posts by CREATION.co revealed health care professionals in various specialties engaging in the online conversation about psilocybin, particularly with regard to studies
The challenge is compounded by evidence suggesting that fake news stories relating to the climate have been increasing for a sustained period, and that the reach when each outbreak of fake news does occur is also growing.
This is supported by the study’s research into planetary health conversation online and internet users. The study shows the growth in the number of internet users globally and the number of authors and posts in online planetary health conversations. Despite seeing a reduction in the level of online conversation surrounding planetary health over the course of the pandemic, more recent figures point to a recovery and a return to the pre-pandemic trajectory.
Fears surrounding the growing ‘infodemic’ have prompted experts, such as Daniel Ghinn, Founder and CEO of Creation Healthcare whose team led on the research with GSK, to urge the healthcare industry to seize the opportunity to play a greater role in combating the spread of online misinformation
Research produced by digital insights company Creation Healthcare also found that Debs was able to engage millions of people through her toughest moments.
Spokeswoman Mary Kangley said: “The enormous impact that Dame Deborah James has had, is clear. Ever since she was first diagnosed, her advocacy and awareness mission hasn’t just touched those suffering from cancer and their loved ones.
“It’s also resonated with the countless doctors, nurses and other healthcare professionals treating cancer day in and day out.”
Calling the research “beyond impressive” and “absolutely remarkable,” HCPs took to Twitter to heap praise on study results presented at the ASCO Annual Meeting describing treatment with dostarlimab in a subset of rectal cancer patients.
The potential for ctDNA-guided management to reduce adjuvant chemotherapy by half without compromising recurrence-free survival sparked interest on social media after a presentation at the ASCO Annual Meeting.
Fresh off a presentation by Jeanne Tie, MD, MBChB, FRACP, on the DYNAMIC trial, Healio and Creation Healthcare, a digital insights company, analyzed health care provider sentiments on the results.
“Research has shown the inescapable influence of social media and the need for a coordinated governmental response to combat fake health news.It’s also shown that doctors and other medical professionals are pioneers and well ahead of governments and health bodies in the fight against medical misinformation, including around COVID-19.”
Click here to view the full article
Commenting on the research, CREATION.co insights data analyst Mark Sullivan said: “Our latest research offers a variety of insights surrounding World Asthma Day 2022. It demonstrates how healthcare professionals and patients themselves are becoming increasingly aware of the environmental implications of different treatment methods and, where possible, ways to mitigate any detrimental effects.”
Click here to view the full article
Commenting on the findings, lead author of the report and Associate Director of Insight at CREATION.co, Jamie Doggett, said:
“The findings of this study are positive and significant. They indicate a high level of social media engagement in the pancreatic cancer conversation on Twitter among clinicians, patients, and the public. Healthcare professionals and advocacy groups can leverage this social media engagement to raise awareness and gain valuable feedback to create an ongoing loop.”
Click here to read the full article
Commenting on the findings, Francesca Gan, Research Associate at Creation Healthcare who led the research, commented:
“Our research makes clear that HCPs within the sickle cell therapy area are widely concerned with the issue of health inequity being faced by those of African or Caribbean descent across the world…With emerging therapies and louder HCP voices speaking out, there is hope that inequity within SCD will cease, and black minorities will receive the treatment deserved in this prevalent therapy area. Creation Healthcare has and will continue to monitor these conversations for the latest in what HCPs think about health equity.”
Click here to read the full article
“The government’s decision to initially recommend a 1% pay award for nurses was the most discussed NHS policy issue among health professionals on social media over a year-long period, it has been revealed.”
Click here to read the full article
“Daniel Ghinn of CREATION.co discusses the growing role social media analysis is playing in helping to provide pharmaceutical companies and health regulators with real-world evidence on drug safety.”
Click here to read the full article
“Using CREATION Pinpoint®, the world’s only AI-powered and human verified global database of more than 3 million healthcare professionals’ social media profiles, Daniel Ghinn, Founder & CEO of CREATION.co reveals how social media and big data analysis is revolutionising our understanding of modern medicine.”
Click here to read the full article
“New research has identified the most active social media users who participate in the UK’s online diabetes debate.
From healthcare professionals to people with the condition, new analysis has disclosed the top ten individuals who have published the most diabetes related posts.”
Click here to read the full article
“A new study reveals the 2020 FE and Secondary exam results season combined with the start of the new academic year triggered a flashpoint of concern among doctors and other healthcare professionals (HCPs) regarding mental health among young people and the prescription of antidepressants during the pandemic.”
Click here to read the full article
“The rise in rates of depression and the devastating toll Coronavirus and lockdown had on the nation’s mental health is well documented. The ONS estimates rates doubled from 2019 to 2020. But, for the first time, a new study by specialist digital healthcare insights and consulting firm, CREATION.co, offers us greater understanding of the drivers behind the rise in rates of mental illness.”
Click here to read the full article
“A new study reveals key flashpoints of concern among doctors and other healthcare professionals (HCPs) regarding public mental health and the prescription of antidepressants during the pandemic.”
Click here to read the full article
“…until Creation Pinpoint, it was impossible to isolate the views of healthcare professionals, whose conversations make up less than 5% of health-related conversations in public social media, from the noise of the public voice…
…within the first six months after its launch, 20 pharmaceutical brands had signed on to use Creation Pinpoint, and by the end of 2014, 60% of the world’s largest pharmaceutical companies were using the service”.
“Creation Healthcare filters social media content and zones in on what HCPs are saying about a specific therapeutic area. Ghinn tells Scrip that Creation Healthcare is currently is working with six of the top ten pharma companies and 20 of the top 50.”
“The idea of a Key Opinion Leader (KOL) can be used both online and in social media, but the problem is that companies don’t always know who their Digital Opinion Leader (DOL) is. DOLs are the people talking online about the pharma company but sometimes there is no direct relationship between the company and the DOL. Creation’s technology helps companies to establish who their DOLs are.”
Linked article behind SCRIP account login.
” The research was pioneered by UK-based specialist digital insights consultancy, Creation Healthcare, working in collaboration with advocacy group Let’s Win! Pancreatic Cancer and leading medical professionals. The findings form part of a collaborative study published in March 2022 in the Journal of Medical Internet Research, a specialist digital health and open science journal.”
Click here to read the full article
Eleanora Teplinsky, MD (@drteplinsky). June 5, 2022. Standing ovation for results of DESTINY-Breast04. This will change practice for 50% of patients with metastatic breast cancer. This is why we all went into this field. #bcsm #ASCO22.
“New analysis of healthcare professionals’ social media posts during this year’s European Association for the Study of Diabetes congress has unveiled the key takeaways relating both to diabetes discussion and the event itself.”
Click here to read the full article
08.07.2022 | PRESS
CREATION.co team growing to better serve their clients
We are excited to announce the newly formed Client Excellence team...
16.05.2022 | PRESS
CREATION.co win Chair’s Award: Best Response to COVID-19 with Frontline.Live at BOBI Awards
CREATION.co win BHBIA BOBI Chair's Award in May 2022
28.04.2022 | PRESS
Environmental impact of respiratory care is key issue surrounding today’s World Asthma Day 2022
The environmental impact of respiratory care has contributed to a significant increase...
14.04.2022 | PRESS
CREATION.co expands into new Maidstone office
This new office is an exciting step for CREATION.co and the team. Over the last 5 years...
08.03.2022 | PRESS
CTO Appointment reflects importance of technology innovation at HCP Insights Consultancy
CTO Appointment reflects importance of technology innovation at HCP Insights Consultancy...
18.02.2022 | PRESS
Healthcare professionals turn to TikTok to reach younger audiences, analysts find
Healthcare professionals turn to TikTok to reach younger audiences, analysts find...
18.02.2022 | PRESS
Healthcare professionals discuss vaccines in the fight against Omicron, with Pfizer vaccine the most discussed
Healthcare professionals discuss vaccines in the fight against Omicron, with Pfizer vaccine
22.12.2021 | PRESS
Positive trial data sees GSK’s Xevudy and Pfizer’s PAXLOVID as most mentioned treatment options in global Omicron fight
Positive trial data sees GSK’s Xevudy most mentioned treatment in global Omicron fight...
29.11.2021 | PRESS
AI-Driven Social Media Analysis Reveals How Medics Changed Their Minds On COVID-19 Vaccine Mixing
Social media is transforming how we interpret and understand modern medicine.
